These findings agree with previous reports from murine models that showed that in tumor-challenged mice, TIGIT deficiency or blockade resulted in better tumor control and that the recovered tumor-infiltrating NK cells had more than double the frequency of TNFα-producing cells and more CD107+ and DNAM+ cells within the tumor-infiltrating NK cell populations. Here, TIGIT is linked to neoplasm.